Panbela Therapeutics Margen de beneficio
¿Qué es el Margen de beneficio de Panbela Therapeutics?
El Margen de beneficio de Panbela Therapeutics Inc. es 0.00%
¿Cuál es la definición de Margen de beneficio?
El margen de ganancia es una medida de la rentabilidad. La misma se calcula al encontrar la ganancia neta como un porcentaje de los ingresos.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Margen de beneficio de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con margen de beneficio similar a Panbela Therapeutics
- Sys plc tiene Margen de beneficio de -0.03%
- e LDLC societe anonyme tiene Margen de beneficio de -0.03%
- IntegraGen SA tiene Margen de beneficio de -0.03%
- Live Ventures Inc tiene Margen de beneficio de -0.03%
- Ever-Glory International tiene Margen de beneficio de -0.03%
- Titagarh Wagons tiene Margen de beneficio de -0.02%
- Panbela Therapeutics tiene Margen de beneficio de 0.00%
- Orange Belgium S.A tiene Margen de beneficio de 0.00%
- Amrapali Industries tiene Margen de beneficio de 0.00%
- Kandi Technologies Inc tiene Margen de beneficio de 0.01%
- Responsive Industries tiene Margen de beneficio de 0.01%
- Stellantis N.V tiene Margen de beneficio de 0.01%
- Adams Resources & tiene Margen de beneficio de 0.01%